
Pantalik 40 Injection
Marketer
Oriel Healthcare Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Pantalik 40 Injection
Acid production in the stomach is decreased by the intravenous medication, GastriCalm 40 Injection. It treats stomach and intestinal ailments linked to excess acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, offering symptom relief and facilitating healing. GastriCalm 40 Injection also prevents stress ulcers in critically ill individuals and is given pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's administered intravenously by medical professionals only when deemed more appropriate than oral medication. Dosage varies based on individual condition and response, with treatment duration determined by your physician; consistent use as directed is crucial, even with rapid symptom improvement. Dietary modifications – frequent, smaller meals; avoidance of caffeine, spicy, and fatty foods – can enhance treatment effectiveness. Common, typically mild, side effects may include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use (over a year) may increase bone fracture risk, particularly at higher doses; discuss bone health (osteoporosis) prevention, such as calcium and vitamin D supplementation, with your doctor. GastriCalm 40 Injection isn't suitable for everyone. Inform your doctor of severe liver disease, HIV medication use, prior allergic reactions to similar drugs, or existing osteoporosis before use. Pregnant or breastfeeding individuals should consult their physician. Alcohol should be avoided due to its acid-stimulating properties. Refrain from operating machinery or driving if dizziness or drowsiness occurs.
Primary Ingredients of Pantalik 40 Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Pantalik 40 Injection
Management of gastroesophageal reflux disorder (GERD), peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Pantalik 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Pantalik 40 Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Pantalik 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Pantalik 40 Injection works:
Gastro-acid control is achieved with Pantalik 40 Injection, a proton pump inhibitor that diminishes gastric acid secretion, thus alleviating symptoms of heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Combining Pantalik 40 Injection and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Pantalik 40 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Pantalik 40 Injection appear compatible. Available data from human studies indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
Pantalik 40 Injection's impact on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Pantalik 40 Injection presents a safe treatment option; no dosage modification is necessary.
LiverCAUTION
For patients exhibiting severe hepatic impairment, administration of Pantalik 40 Injection requires careful monitoring. Dosage modification of Pantalik 40 Injection might be necessary. Physician consultation is advised.
What if you forget to take Pantalik 40 Injection :
Omitting a scheduled Pantalik 40 Injection warrants immediate physician consultation.
Facts to Know About Pantalik 40 Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavioral Class | Gastric acid suppressants |
